PLoS One 10 (10), e0139593
Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine , 2021;384:9891002
Research-chemical vials sold as cagrilintide or retatrutide are of unverified identity and purity
Results May Vary: Individual results will vary based on factors including age, baseline health condition, lifestyle factors, consistency of use, genetic factors, current medications, diet and exercise habits, and other individual variables
If your compounded semaglutide contains additional ingredients beyond the active pharmaceutical ingredient and a standard vehicle, ask specifically why those ingredients are included and what evidence supports their addition